Abstract
Drug-eluting stent (DES) with femoropopliteal lesions have improved patency results. However, long lesions were excluded from current study. The treatment of in-stent-restenosis in the femoropopliteal artery is still unsolved problem. Furthermore, there was no significant difference in patency for
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
